|
|
 |
| |
|
|
|
|
 10-year history of clinical success in a variety of ENT applications
Published results demonstrate that AlloDerm® Regenerative Tissue Matrix has been used in a variety of ENT applications. From parotidectomy to injection laryngoplasty, surgeons have seen benefits of using AlloDerm® Tissue Matrix as an alternative to autologous tissue or other sources.
Histological examination of a human biopsy of AlloDerm® Tissue Matrix, obtained from an ENT surgery patient who underwent total parotidectomy.*
AlloDerm® Tissue Matrix supports remodeling into functional host tissue that has fascia-like architecture distinct from that of scar tissue.
22-month human biopsy of AlloDerm® Tissue Matrix total parotidectomy
Verhoeff’s stain for elastin (40x), inset (100x); human biopsy at 22 months. When placed in a sub-dermal plane, the AlloDerm® Tissue Matrix appears to retain the dermal architecture. Also, the elastin-negative zone between the AlloDerm® Tissue Matrix layers is suggestive of a fibrovascular layer similar to a thin layer of scar between the layers of AlloDerm® Tissue Matrix dermis.
H&E stain; human biopsy at 22 months. H&E staining indicates that the collagen architecture and fibroblast density are indicative of normal-appearing dermis regenerated on the AlloDerm® Tissue Matrix scaffold rather than scar tissue.
*Patient results may vary.
Before use, physicians should review all risk information and essential prescribing information which can be found in the AlloDerm® Regenerative Tissue Matrix Instructions for Use. |
|
|
|
|
